C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
2.100
+0.190 (9.95%)
Feb 19, 2026, 4:00 PM EST - Market closed
C4 Therapeutics Market Cap
C4 Therapeutics has a market cap or net worth of $203.52 million as of February 19, 2026. Its market cap has decreased by -14.19% in one year.
Market Cap
203.52M
Enterprise Value
56.50M
1-Year Change
-14.19%
Ranking
Category
Stock Price
$2.10
Market Cap Chart
Since the IPO on October 2, 2020, C4 Therapeutics's market cap has decreased from $772.72M to $203.52M, a decrease of -73.66%. That is a compound annual growth rate of -21.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 185.11M | - |
| Dec 31, 2025 | 185.11M | -27.16% |
| Dec 31, 2024 | 254.12M | -8.73% |
| Dec 29, 2023 | 278.44M | -3.60% |
| Dec 30, 2022 | 288.85M | -81.55% |
| Dec 31, 2021 | 1.57B | 9.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tonix Pharmaceuticals Holding | 193.70M |
| Voyager Therapeutics | 188.48M |
| Sol-Gel Technologies | 187.20M |
| Ovid Therapeutics | 184.86M |
| Prelude Therapeutics | 183.75M |
| SAB Biotherapeutics | 183.29M |
| Galectin Therapeutics | 177.94M |
| Tiziana Life Sciences | 177.40M |